According to a regulatory filing, on November 6, 2025, Inspire Medical (INSP) Systems, Inc. disclosed its expectation to release a significant portion of the valuation allowance on its U.S. deferred tax assets during the fourth quarter of fiscal 2025. The company estimates that this release will result in an income tax benefit in the range of $90M to $100M for the year, which is expected to increase diluted earnings per share by approximately $3.00 to $3.30 for the same period.
TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on INSP: